Puma Biotech (PBYI), Pierre Fabre Amend NERLYNX® License Agreement to Include Greater China
Go back to Puma Biotech (PBYI), Pierre Fabre Amend NERLYNX® License Agreement to Include Greater China| PUMA BIOTECHNOLOGY, Inc. (NASDAQ: PBYI) | Delayed: 9.05 -0.34 (3.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.39 | 52 Week High | $82.81 | |||
| Open | $9.31 | 52 Week Low | $19.74 | |||
| Day High | $9.45 | P/E | N/A | |||
| Day Low | $9.01 | EPS | $-2.16 | |||
| Volume | 453,606 | |||||
